Daily Analysis Report
Veye offers fundamental and technical analysis of stocks, covered in our daily reports, primarily listed on the ASX and occasionally on the NYSE/Nasdaq. These reports highlight not only potentially lucrative investment opportunities but also offer analysis of the holdings with clear recommendations of Buy, Hold or Sell.
This analysis will be handy to those investors seeking regular updates on covered stocks and help them in streamlining their portfolios.
Following an initial screening process, our research analysts identify stocks across established and emerging sectors. We focus on companies with sound business models and attractive long-term growth prospects, as well as stocks showing signs of recovery following price corrections.
While no investment outcome is guaranteed, Veye’s research-driven approach aims to help investors make informed decisions and identify companies capable of delivering substantial returns over time.
Features
✓ Inclusive Daily Analysis Report to keep up with the latest on what's hot and what's not, Our analysts give their views on the recent market movements and developments, and what it all means.
✓ Buy, Sell and Hold recommendations.
✓ Risk Rating: Low-Medium
Report Frequency : Mon to Fri
Publishing Time : 9:00 AM AEST
Price
Price |
$149 /
12 Months
(incl. of GST)
Our subscription comes with 14 days cooling-off period, however, it only applies to new subscribers.
We sell results, not just reports!
At Veye, we understand that making investment decisions can be a daunting task. That’s why we offer comprehensive market research on ASX stocks to help investors navigate the complexities of the market and make informed decisions about buying, selling or holding stocks. Our team of expert analysts conducts rigorous research and analysis to provide unbiased recommendations on a range of stocks across various industries. Our reports are designed to be accessible to all investors, regardless of their level of experience or financial expertise.
Subscribe NowFrequently Asked Questions
Past Recommendations
| Code | Avg Buy | Avg Sell | Gain/loss |
|---|---|---|---|
| Vanadium Resources Ltd (ASX: VR8) | $0.043 | $0.061 | +41.86% |
| Krystal Biotech Inc (NASDAQ: KRYS) | $178.93 | $337.08 | +88.39% |
| Tamawood Ltd (ASX: TWD) | $3.025 | $3.665 | +21.16% |
| Ross Stores Inc. (NYSE: ROST) | $145.785 | $239.148 | +64.04% |
| Broadcom Inc. (NASDAQ: AVGO) | $166.13 | $361.58 | +117.65% |
| IMDEX Ltd (ASX: IMD) | $2.187 | $3.7062 | +69.47% |
Disclaimer: Not every company performs as expected. Past performance is not an indication of future returns. “Gain/Loss” reflects movement in difference in average buy price and sell price plus dividends as a percentage of average buy price, and does not take into account costs or taxation.